Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001658021-25-000002
Filing Date
2025-07-02
Accepted
2025-07-02 15:44:12
Documents
1
Effectiveness Date
2025-07-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9346
  Complete submission text file 0001658021-25-000002.txt   10420
Mailing Address 202 WASHINGTON STREET, SUITE 318 BROOKLINE MA 02445
Business Address 202 WASHINGTON STREET, SUITE 318 BROOKLINE MA 02445 617-468-4646
General Oncology, Inc. (Filer) CIK: 0001658021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-343809 | Film No.: 251100606